1 min read
Add as a preferred source on GoogleGeneDx Shares Slide as Fourth-Quarter Revenue Outlook Misses Estimates
Third-quarter 2026 revenue exceeded consensus estimates, while the next-quarter forecast fell below market expectations.
GeneDx Holdings Corp. (WGS) shares declined in premarket trading Tuesday, Nov. 10, after the genetic testing company issued a fourth-quarter revenue outlook below market expectations. Third-quarter 2026 revenue exceeded consensus estimates.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.